Role of ¹⁸F-FDG PET Metabolic Parameters in Treatment Response Evaluation and Prognostic Assessment of Hodgkin Lymphoma: A Retrospective Analysis

Key Points

• This research aims to assess the role of metabolic parameters in predicting treatment response and prognosis in Hodgkin lymphoma.
• Conducted a retrospective analysis of Hodgkin lymphoma cases
• Evaluated baseline volumetric parameters and long-interval metabolic changes
• Used ΔSUVmax₁₋₃ for risk stratification
• Baseline volumetric parameters identified as strong prognostic markers
• ΔSUVmax₁₋₃ provided additional risk stratification
• Dynamic PET metrics support clinical decision-making